Persistence of Tofacitinib Treatment in Patients With Ulcerative Colitis Who Entered the Open-Label, Long-Term Extension Study, OCTAVE OPEN Without a Clinical Response

被引：0
|
作者：
Panaccione, Remo [1 ]
Abreu, Maria T. [2 ]
Lazariciu, Irina [3 ]
Mundayat, Rajiv [3 ]
Lawendy, Nervin [4 ]
Salese, Leonardo [4 ]
Woolcott, John C. [4 ]
Sands, Bruce E. [5 ]
Chaparro, Maria [6 ,7 ]
机构：
[1] Univ Calgary, Cumming Sch Med, Inflammatory Bowel Dis Clin, Gastrointestinal Res, Calgary, AB, Canada
[2] Univ Miami, Miller Sch Med, Crohns & Colitis Ctr, Miami, FL 33136 USA
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Inc, Collegeville, PA USA
[5] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
[6] Univ Autonoma Madrid, Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IIS IP, Madrid, Spain
[7] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S761
引用
收藏
页码：S351 / S352
页数：2
相关论文
共 50 条
  • [41] Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
    Michael Spaeth
    Cayetano Alegre
    Serge Perrot
    Youyu Grace Wang
    Diane R Guinta
    Sarah Alvarez-Horine
    Irwin Jon Russell
    Arthritis Research & Therapy, 15
  • [42] Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
    Spaeth, Michael
    Alegre, Cayetano
    Perrot, Serge
    Wang, Youyu Grace
    Guinta, Diane R.
    Alvarez-Horine, Sarah
    Russell, Irwin Jon
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [43] LONG-TERM PERAMPANEL USE IN OPEN-LABEL EXTENSION STUDIES
    Rektor, Ivan
    Krauss, Gregory L.
    Inoue, Yushi
    Kaneko, Sunao
    Williams, Betsy
    Patten, Anna
    Bibbiani, Francesco
    Laurenza, Antonio
    Wechsler, Robert T.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A23 - A23
  • [44] Tofacitinib for the Treatment of Patients with Juvenile Idiopathic Arthritis: An Interim Analysis of Data up to 5.5 Years from an Open-label, Long-term Extension Study
    Brunner, Hermine I.
    Akikusa, Jonathan
    Al-Abadi, Eslam
    Bohnsack, John
    Boteanu, Alina Lucica
    Chedeville, Gaelle
    Cuttica, Ruben
    De La Pena, Wendy
    Jung, Lawrence
    Kasapcopur, Ozgur
    Kobusinska, Katarzyna
    Schulert, Grant
    Neiva, Claudia
    Rivas-Chacon, Rafael
    Rodriguez, Juan Cruz Rizo
    Vazquez-Del Mercado, Monica
    Wagner-Weiner, Linda
    Weiss, Jennifer E.
    Wouters, Carine
    Suehiro, Ricardo M.
    Posner, Holly
    Wouters, Ann
    Kanik, Keith S.
    Luo, Zhen
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [45] Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
    Barratt, Jonathan
    Barbour, Sean
    Brenner, Robert
    Cooper, Kerry
    Wei, Xuelian
    Eren, Necmi
    Floege, Juergen
    Jha, Vivekanand
    Kim, Sung Gyun
    Maes, Bart
    Phoon, Richard K. S.
    Singh, Harmeet
    Tesar, Vladimir
    Lafayette, Richard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024,
  • [46] LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY
    Ketter, Terence A.
    Sarma, Kaushik
    Silva, Robert
    Kroger, Hans
    Cucchiaro, Josephine
    Loebel, Antony
    DEPRESSION AND ANXIETY, 2016, 33 (05) : 424 - 434
  • [47] Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis
    Gladman, Dafna D.
    Nash, Peter
    Mease, Philip J.
    Fitzgerald, Oliver
    Duench, Stephanie
    Cadatal, Mary Jane
    Masri, Karim R.
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [48] Efficacy and Safety of Tofacitinib in an Open-Label, Long-Term Extension Study in Patients with Psoriatic Arthritis Who Received Adalimumab or Tofacitinib in a Phase 3 Randomized Controlled Study: A Post Hoc Analysis
    Gladman, Dafna
    Nash, Peter
    Mease, Philip J.
    FitzGerald, Oliver
    Masri, Karim R.
    Duench, Stephanie
    Jane Cadatal, Mary
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2798 - 2801
  • [49] Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study
    Pozo-Rosich, Patricia
    Detke, Holland C.
    Wang, Shufang
    Dolezil, David
    Li, Lily Q.
    Aurora, Sheena K.
    Reuter, Uwe
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (05) : 731 - 742
  • [50] Long-Term Soticlestat Treatment in Patients with Developmental and/or Epileptic Encephalopathies in the ENDYMION Ongoing Open-Label Extension Study
    Hahn, Cecil D.
    Jiang, Yuwa
    Villanueva, Vincente
    Zolnowska, Marta
    Arkilo, Dimitrios
    Forgacs, Peter B.
    Asgharnejad, Mahnaz
    Yan, Ying
    Dlugos, Dennis
    NEUROLOGY, 2021, 96 (15)
12345